1. Home
  2. QMCO vs UNCY Comparison

QMCO vs UNCY Comparison

Compare QMCO & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QMCO
  • UNCY
  • Stock Information
  • Founded
  • QMCO 1980
  • UNCY 2016
  • Country
  • QMCO United States
  • UNCY United States
  • Employees
  • QMCO N/A
  • UNCY N/A
  • Industry
  • QMCO Electronic Components
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • QMCO Technology
  • UNCY Health Care
  • Exchange
  • QMCO Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • QMCO 86.9M
  • UNCY 91.0M
  • IPO Year
  • QMCO N/A
  • UNCY 2021
  • Fundamental
  • Price
  • QMCO $8.43
  • UNCY $6.34
  • Analyst Decision
  • QMCO Hold
  • UNCY Strong Buy
  • Analyst Count
  • QMCO 2
  • UNCY 4
  • Target Price
  • QMCO $19.00
  • UNCY $6.38
  • AVG Volume (30 Days)
  • QMCO 2.6M
  • UNCY 867.0K
  • Earning Date
  • QMCO 08-12-2025
  • UNCY 08-13-2025
  • Dividend Yield
  • QMCO N/A
  • UNCY N/A
  • EPS Growth
  • QMCO N/A
  • UNCY N/A
  • EPS
  • QMCO N/A
  • UNCY N/A
  • Revenue
  • QMCO $285,865,000.00
  • UNCY N/A
  • Revenue This Year
  • QMCO N/A
  • UNCY N/A
  • Revenue Next Year
  • QMCO $2.46
  • UNCY $1,458.53
  • P/E Ratio
  • QMCO N/A
  • UNCY N/A
  • Revenue Growth
  • QMCO N/A
  • UNCY N/A
  • 52 Week Low
  • QMCO $2.22
  • UNCY $2.02
  • 52 Week High
  • QMCO $90.64
  • UNCY $11.00
  • Technical
  • Relative Strength Index (RSI)
  • QMCO 35.79
  • UNCY 48.29
  • Support Level
  • QMCO $9.81
  • UNCY $4.70
  • Resistance Level
  • QMCO $10.69
  • UNCY $7.58
  • Average True Range (ATR)
  • QMCO 0.85
  • UNCY 1.20
  • MACD
  • QMCO -0.25
  • UNCY -0.07
  • Stochastic Oscillator
  • QMCO 5.09
  • UNCY 26.03

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: